However, since survivin seems to play such an important role in cell division and appears to be necessary to tumor cell survival, if it can be exploited then immunotherapy aimed at survivin would be effective at any stage of prostate cancer and in many different types of cancer [55]. This evidence concerns the gene BIRC5 and neoplasm.